STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching
Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.